Lembas: $3.6 Million Raised For AI-Based Bioactive Peptide Discovery
By Amit Chowdhry ● Jun 22, 2025
Lembas, an AI-based bioactive peptide discovery company, announced it has emerged from stealth mode with a scientific breakthrough in activating GLP-1, the key hormone that helps regulate appetite and metabolism. And the company closed an oversubscribed pre-seed funding round of $3.6 million led by FLORA Ventures, which also incubated the company, with participation from a group of leading venture capital funds, Bluestein Ventures, Fresh Fund, Longevity Venture Partners, Maia Ventures, Siddhi Capital, Mandi Ventures, and SDH.